tirzepatide for sleep apnea fda approval Approves First Drug What clinicians should know about

Key takeaways Yes, diarrhea is a known side effect of semaglutide especially when first starting or increasing the dose

Some experts have postulated that GLP-1 receptors could be protective against cytokine-mediated apoptosis (cell death) and may also stimulate neurogenesis (cell life)

EudraCT number, 2020-002723-11.) Phase 2 Trial of Survodutide in MASH and Fibrosis In this phase 2 trial involving adults with metabolic dysfunction-associated steatohepatitis and liver fibrosis, survodutide was superior to placebo with respect to improvement in MASH without worsening of fibrosis.

Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control PMC.